Search
for
Sort by
Research 31–60 of 353
- Targeted therapy in melanoma
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
- America - A Diversity of Life Styles.
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Biological therapy in the treatment of melanoma
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Dermatologic Adverse Events from Cancer Treatments
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- B-Raf and C-Raf Are Required for Melanocyte Stem Cell Self-Maintenance
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Dermatologic Reactions to Targeted Therapy
- An overview of management of drug-induced hair and nail disorders
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Research Progress on the Application of Stem Cells in Hair Regeneration
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Cancer Treatments and Alopecia: A Systematic Review